Pharmaceutical Caps and Closure Packaging Market by Type (Screw Caps, Crimp-ons, Press-ons, Roll-ons, Frictions), Material (Plastic, Elastomer, Metal), Packaging Type (Child-resistant, Tamper-evident, End User, and Region - Global Forecast to 2030

icon1
USD 32.77 BN
MARKET SIZE, 2030
icon2
CAGR 15%
(2025-2030)
icon3
200
REPORT PAGES
icon4
130
MARKET TABLES

OVERVIEW

pharmaceutical-caps-and-closure-packaging-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global pharmaceutical caps and closure packaging market was valued at USD 16.15 billion in 2025 and is expected to reach USD 32.77 billion by 2030, growing at a CAGR of 15.0% during the forecast period. Pharmaceutical caps and closures are essential packaging components designed to protect pharmaceutical products from contamination, ensure product integrity, and maintain compliance with stringent regulatory requirements. These packaging solutions encompass various closure types, including screw caps, crimp-ons, press-ons, roll-ons, and friction closures that serve critical functions in preserving drug efficacy and patient safety. Market growth is driven by increasing demand for secure and sustainable packaging solutions, technological advancements in packaging materials, the rise in pharmaceutical contract manufacturing, and innovative design implementations that address both safety and compliance requirements across the pharmaceutical industry.

KEY TAKEAWAYS

  • By Region
    North America led the pharmaceutical caps and closure packaging market, valued at USD 4.7 billion in 2025, and is projected to grow at a CAGR of 14.5% during the forecast period.
  • By Material
    Plastic dominates due to cost efficiency and versatility, accounting for 55% share of the overall market in 2024.
  • By Application
    Screw caps and closures represent the dominant application segment, accounting for 45% share of the pharmaceutical caps & closure packaging market in 2024.
  • By Packaging Type
    Child-resistant packaging is the largest segment with a share of 28% of the overall market in 2024.
  • Competitive Landscape - Star Players
    Amcor plc (Switzerland), Gerresheimer AG (Germany), AptarGroup (US), West Pharmaceutical Services (US), and Silgan Holdings (US) were identified as leading players in the pharmaceutical caps and closure packaging market, given their strong market presence, extensive product portfolios, and continuous innovation through new product launches and strategic collaborations.
  • Competitive Landscape - Startups
    Weener Plastics Group and Bericap have distinguished themselves through specialized capabilities in digitally networked closures and advanced compliance solutions, underscoring their potential as emerging market leaders in innovative pharmaceutical caps and closure packaging technologies.

The global pharmaceutical caps and closure packaging market is experiencing robust growth driven by increasing regulatory requirements for drug safety and the expanding pharmaceutical manufacturing sector worldwide.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The pharmaceutical caps and closure packaging market is currently experiencing a phase of innovation and rapid adoption driven by evolving regulatory frameworks and patient safety requirements. Healthcare systems and pharmaceutical manufacturers across North America, Europe, Asia Pacific, and other regions are witnessing advancements in closure technology development and regulatory compliance. This progress aligns with emerging trends in child-resistant packaging, tamper-evident solutions, and digitally networked closures for improved medication administration monitoring. In the pharmaceutical industry, the use of advanced materials such as polypropylene and polyethylene is increasing among drug manufacturers and contract packaging organizations. These materials facilitate the development of closures that ensure drug preservation, reduce contamination risks, and align with regulatory guidelines mandated by the FDA and CPSC. Governments and regulatory bodies are encouraging innovation in packaging design, the development of digitally integrated closures for patient compliance monitoring, and public-private research programs. These initiatives help accelerate approval timelines and promote the adoption of technologically advanced, clinically validated closure platforms tailored to the needs of diverse pharmaceutical applications and patient populations.

pharmaceutical-caps-and-closure-packaging-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Increasing focus on drug preservation and safety facilitated by stringent regulatory frameworks
  • Growing demand for child-resistant and tamper-evident packaging solutions
RESTRAINTS
Impact
Level
  • Fluctuating raw material prices and high costs associated with implementing advanced technologies
OPPORTUNITIES
Impact
Level
  • Expanding pharmaceutical contract manufacturing sector and demand for small and medium-sized closures
CHALLENGES
Impact
Level
  • Maintaining balance between innovation and cost efficiency while countering proliferation of counterfeit drugs

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Increasing focus on drug preservation and safety facilitated by stringent regulatory frameworks

The increasing focus on drug preservation and patient safety across the pharmaceutical industry, supported by stringent regulatory frameworks such as the FDA and CPSC guidelines mandating child-resistant packaging, is driving greater adoption of advanced caps and closures. Pharmaceutical manufacturers and packaging companies are investing in innovative closure technologies that ensure product integrity, prevent contamination, and comply with evolving safety standards, which is increasing the use of specialized caps and closures in pharmaceutical packaging applications.

Restraint: Fluctuating raw material prices and high costs associated with implementing advanced technologies

Fluctuating raw material prices and the high costs associated with implementing advanced packaging technologies restrict the adoption of innovative pharmaceutical caps and closures. Price volatility in polypropylene, polyethylene, and other packaging materials, combined with significant capital investment requirements for advanced manufacturing capabilities, create challenges for manufacturers trying to introduce cost-effective yet technologically sophisticated closure solutions across the market.

Opportunity: Expanding pharmaceutical contract manufacturing sector and demand for small and medium-sized closures

The expanding pharmaceutical contract manufacturing sector and growing demand for small and medium-sized closures present significant growth opportunities in the pharmaceutical packaging market. These specialized closure solutions are increasingly utilized in contract packaging operations, specialized drug formulations, and personalized medicine applications, aligning well with the industry focus on flexible manufacturing and customized packaging solutions.

Challenge: Maintaining balance between innovation and cost efficiency while countering proliferation of counterfeit drugs

Maintaining a balance between innovation and cost efficiency remains a key challenge while simultaneously addressing the proliferation of counterfeit drugs in the pharmaceutical supply chain. Manufacturers must invest in advanced anti-counterfeiting technologies, quality control systems, and compliance validation to ensure product authenticity and patient safety while managing production costs and maintaining competitive pricing for pharmaceutical caps and closure solutions.

PHARMACEUTICAL CAPS AND CLOSURE PACKAGING MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Amcor plc supplies innovative pharmaceutical packaging solutions, including the AmSky packaging system and advanced closure technologies, to pharmaceutical manufacturers across North America, Europe, and the Asia Pacific for drug preservation, contamination prevention, and regulatory compliance in various pharmaceutical applications Ensures superior product protection, maintains drug efficacy, supports regulatory compliance, and enables secure packaging for diverse pharmaceutical products while meeting stringent safety and quality standards.
Gerresheimer AG provides high-precision pharmaceutical caps and closures, including the Gx Cap digital closure system to pharmaceutical companies and contract manufacturers for enhanced patient compliance monitoring, medication administration tracking, and advanced drug packaging applications. Delivers enhanced patient compliance capabilities, supports digital health integration, provides tamper-evident security, and enables pharmaceutical companies to meet evolving regulatory requirements and patient safety standards.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The pharmaceutical caps and closure packaging market is a collaborative ecosystem where packaging material suppliers, pharmaceutical manufacturers, contract packaging organizations, technology providers, and healthcare professionals work together to develop and implement advanced closure solutions in the pharmaceutical sector. Companies in the market supply a variety of caps and closures, including screw caps, crimp-ons, press-ons, roll-ons, and friction closures manufactured from materials such as polypropylene, polyethylene, and other specialized polymers. Contract development and manufacturing organizations, pharmaceutical companies, and packaging specialists across North America, Europe, Asia Pacific, South America, and the Middle East and Africa support the development, testing, and scale-up process for these packaging solutions. Ultimately, pharmaceutical manufacturers and healthcare providers utilize the developed caps and closures, benefiting from supportive regulations, safety guidelines, and quality standards that ensure product integrity and patient safety.

pharmaceutical-caps-and-closure-packaging-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

pharmaceutical-caps-and-closure-packaging-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Pharmaceutical Caps and Closure Packaging Market, by Material

The pharmaceutical caps and closure packaging market is currently experiencing its fastest growth through plastic caps and closures because these products provide lightweight design and cost-effective value, and they can be used to package various oral solid, liquid, and over-the-counter medications products. The market expansion results from two main factors: the growing need for child-resistant and tamper-proof packaging and the development of advanced polymers that provide better chemical protection and reduced substance transfer. The increasing use of sustainable, recyclable plastic solutions, together with growing pharmaceutical production in developing countries, drives the adoption of plastic closure systems.

Pharmaceutical Caps and Closure Packaging Market, by Application

Screw caps and closures represented the largest segment of the pharmaceutical caps and closure packaging market. The increasing demand for child-resistant and tamper-evident packaging has propelled this segment to the forefront in the industry. Factors such as stringent regulatory requirements mandated by the FDA and CPSC, growing concerns about medication safety, patient compliance needs, and the prevention of accidental ingestion are driving the demand for advanced screw cap closures, child-resistant packaging solutions, and tamper-evident closure systems.

REGION

North America to maintain leadership position in market during forecast period

North America is the leading region in the pharmaceutical caps and closure packaging market, valued at USD 4.70 billion in 2025 and is projected to grow at a CAGR of 14.5% between 2025 and 2030, driven by stringent safety regulations, well-established pharmaceutical manufacturing infrastructure, and strong regulatory frameworks governing pharmaceutical packaging. The demand for child-resistant closures, tamper-evident packaging, and advanced closure technologies is increasing across the region, driven by FDA and CPSC guidelines mandating specific safety features for pharmaceutical products. Additionally, significant investment in pharmaceutical contract manufacturing, combined with a mature healthcare system and a focus on patient safety, is facilitating the continued adoption of innovative caps and closures from research and development to commercial implementation.

pharmaceutical-caps-and-closure-packaging-market Region

PHARMACEUTICAL CAPS AND CLOSURE PACKAGING MARKET: COMPANY EVALUATION MATRIX

Amcor plc, recognized as a leading player in the pharmaceutical caps and closure packaging market, offers a diverse portfolio that includes innovative closure systems, child-resistant packaging, tamper-evident solutions, and the AmSky packaging technology for pharmaceutical applications. The company boasts a strong manufacturing presence globally and collaborates with pharmaceutical manufacturers, contract packaging organizations, and healthcare providers across North America, Europe, the Asia Pacific, and other regions. Another significant player in the market is Gerresheimer AG, identified as a leading innovator. The company is strengthening its position by introducing advanced closure technologies, including the Gx Cap high-precision digital closure system, bioresorbable materials, and specialty packaging solutions designed for enhanced patient compliance, medication monitoring, and diverse pharmaceutical applications.

pharmaceutical-caps-and-closure-packaging-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 16.15 Billion
Market Forecast in 2030 (Value) USD 32.77 Billion
Growth Rate CAGR of 15.0% from 2025–2030
Years Considered 2022–2030
Base Year 2024
Forecast Period 2025–2030
Units Considered Value (USD Billion)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • Type:
    • Screw Caps
    • Crimp-Ons
    • Press-Ons
    • Roll-Ons
    • Frictions
  • Material:
    • Plastic
    • Elastomer
    • Metal
  • Packaging Type Child-resistant Packaging, Tamper-evident Packaging, Standard Closures
  • End User:
    • Pharmaceutical Manufacturing
    • Contract Manufacturing Organizations
    • Biotechnology Companies
    • Healthcare Facilities
    • Retail Pharmacies
    • Hospital & Clinical
    • Nutraceuticals
Regions Covered North America, Europe, Asia Pacific, South America, Middle East and Africa

WHAT IS IN IT FOR YOU: PHARMACEUTICAL CAPS AND CLOSURE PACKAGING MARKET REPORT CONTENT GUIDE

pharmaceutical-caps-and-closure-packaging-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Understanding demand patterns for pharmaceutical caps and closures across global pharmaceutical manufacturing systems Assessed pharmaceutical caps and closure usage trends across key regions, including North America, Europe, Asia Pacific, South America, and the Middle East and Africa, highlighting differences in the adoption of screw caps, crimp-ons, press-ons, roll-ons, and friction closures across various pharmaceutical applications and regulatory environments Helps clients align product portfolios with region-specific regulatory requirements, material preferences, safety standards, and pharmaceutical manufacturing volumes
Identifying material sourcing and manufacturing opportunities Mapped regional pharmaceutical packaging suppliers, contract manufacturers, and closure technology providers across North America, Europe, and the Asia Pacific, with insights into polypropylene and polyethylene processing, advanced closure manufacturing, child-resistant technology implementation, and pharmaceutical-grade material supply Supports localization strategies, reduces supply-chain risk, lowers production costs, ensures regulatory compliance, and improves speed-to-market for pharmaceutical packaging solutions

RECENT DEVELOPMENTS

  • October 2023 : Gerresheimer AG launched Gx Cap, a high-precision digital closure system designed for enhanced patient compliance monitoring and medication administration tracking, demonstrating advanced technological integration and improved functionality for pharmaceutical packaging applications.
  • March 2023 : Amcor plc entered a strategic partnership with Berry Global to enhance its healthcare packaging segment, expanding capabilities in pharmaceutical closure solutions and strengthening its market position in advanced packaging technologies for the pharmaceutical industry.
  • September 2022 : Amcor plc secured a major contract with a leading pharmaceutical company for its innovative AmSky packaging system, demonstrating market confidence in advanced pharmaceutical packaging solutions and supporting the company's growth in specialized closure technologies.
  • August 2022 : Gerresheimer AG completed the acquisition of flexible packaging capabilities to expand its product offerings in the pharmaceutical packaging sector, broadening its portfolio of closure solutions and strengthening its position in the global pharmaceutical caps and closures market.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
15
2
EXECUTIVE SUMMARY
 
 
 
 
 
3
PREMIUM INSIGHTS
 
 
 
 
 
4
MARKET OVERVIEW
Summarizes the competitive environment, macro signals, and segment-level movements driving market outcomes.
 
 
 
 
 
 
4.1
INTRODUCTION
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
4.3
UNMET NEEDS AND WHITE SPACES
 
 
 
 
 
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
5
INDUSTRY TRENDS
Covers the key developments, trend analysis, and actionable insights to support strategic planning and positioning.
 
 
 
 
 
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
5.2
MACROECONOMIC OUTLOOK
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
5.2.2
GDP TRENDS AND FORECAST
 
 
 
 
 
5.2.3
TRENDS IN PACKAGING INDUSTRY
 
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
 
5.5.1
AVERAGE SELLING PRICE TREND, BY TYPE (2022–2025)
 
 
 
 
 
5.5.2
AVERAGE SELLING PRICE TREND OF PHARMACEUTICAL CAPS AND CLOSURE MATERIALS, BY KEY PLAYER (2022–2025)
 
 
 
 
 
5.5.3
AVERAGE SELLING PRICE TREND, BY REGION (2022–2025)
 
 
 
 
5.6
TRADE ANALYSIS
 
 
 
 
 
 
 
5.6.1
IMPORT SCENARIO (HS CODE 390461)
 
 
 
 
 
5.6.2
EXPORT SCENARIO (HS CODE 390461)
 
 
 
 
5.7
KEY CONFERENCES AND EVENTS, 2026–2027
 
 
 
 
 
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
5.9
INVESTMENT AND FUNDING SCENARIO
 
 
 
 
 
5.10
CASE STUDY ANALYSIS
 
 
 
 
 
5.11
IMPACT OF 2025 US TARIFF – PHARMACEUTICAL CAPS AND CLOSURE PACKAGING MARKET
 
 
 
 
 
 
 
5.11.1
INTRODUCTION
 
 
 
 
 
5.11.2
KEY TARIFF RATES
 
 
 
 
 
5.11.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
5.11.4
IMPACT ON COUNTRIES/REGIONS
 
 
 
 
 
 
5.11.4.1
US
 
 
 
 
 
5.11.4.2
EUROPE
 
 
 
 
 
5.11.4.3
ASIA PACIFIC
 
 
 
5.11.5IMPACT ON END-USE INDUSTRIES
 
 
 
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
 
 
 
 
 
 
6.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
 
6.1.1
SMART PHARMACEUTICAL CAPS AND CLOSURES PACKAGING
 
 
 
 
 
6.1.2
SUSTAINABLE HIGH-BARRIER MATERIALS
 
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
6.2.1
HIGH-SPEED PACKAGING AUTOMATION & ROBOTICS
 
 
 
 
 
6.2.2
UNIT-DOSE & ADHERENCE-ORIENTED PACKAGING FORMATS
 
 
 
 
6.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
6.3.1
ADVANCED PRINTING & SERIALIZATION TECHNOLOGIES
 
 
 
 
 
6.3.2
MODIFIED ATMOSPHERE & ACTIVE PACKAGING CONCEPTS
 
 
 
 
6.4
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
6.5
PATENT ANALYSIS
 
 
 
 
 
 
6.6
FUTURE APPLICATIONS
 
 
 
 
 
6.7
IMPACT OF AI/GEN AI ON PHARMACEUTICAL CAPS AND CLOSURE PACKAGING MARKET
 
 
 
 
 
 
 
6.6.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
6.6.2
BEST PRACTICES IN PHARMACEUTICAL CAPS AND CLOSURE PACKAGING
 
 
 
 
 
6.6.3
CASE STUDIES OF AI IMPLEMENTATION IN PHARMACEUTICAL CAPS AND CLOSURE PACKAGING MARKET
 
 
 
 
 
6.6.4
INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
 
6.6.5
CLIENTS’ READINESS TO ADOPT AI IN PHARMACEUTICAL CAPS AND CLOSURE PACKAGING MARKET
 
 
 
7
REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES
 
 
 
 
 
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
 
7.2
SUSTAINABILITY INITIATIVES
 
 
 
 
 
7.3
IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
 
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
 
 
 
 
 
 
8.1
INTRODUCTION
 
 
 
 
 
8.2
DECISION-MAKING PROCESS
 
 
 
 
 
8.3
KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
 
 
 
 
 
 
8.3.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
8.3.2
BUYING CRITERIA
 
 
 
 
8.4
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
8.5
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
 
8.6
MARKET PROFITABILITY
 
 
 
 
9
PHARMACEUTICAL CAPS AND CLOSURE PACKAGING MARKET, BY TYPE (MARKET SIZE & FORECAST TO 2030 – IN VALUE, USD MILLION)
 
 
 
 
 
 
COMPARATIVE ASSESSMENT OF KEY TYPES, THEIR MARKET POTENTIAL, AND DEMAND PATTERNS
 
 
 
 
 
 
9.1
INTRODUCTION
 
 
 
 
 
9.2
SCREW CAPS
 
 
 
 
 
9.3
CRIMP-ONS
 
 
 
 
 
9.4
PRESS-ONS
 
 
 
 
 
9.5
ROLL-ONS
 
 
 
 
 
9.6
FRICTIONS
 
 
 
 
10
PHARMACEUTICAL CAPS AND CLOSURE PACKAGING MARKET, BY PACKAGING TYPE (MARKET SIZE & FORECAST TO 2030 – IN VALUE, USD MILLION)
 
 
 
 
 
 
ANALYSIS OF REQUIREMENT OF PHARMACEUTICAL CAPS AND CLOSURE PACKAGING IN VARIOUS PACKAGING TYPES
 
 
 
 
 
 
10.1
INTRODUCTION
 
 
 
 
 
10.2
CHILD-RESISTANT PACKAGING
 
 
 
 
 
10.3
TAMPER-EVIDENT PACKAGING
 
 
 
 
 
10.4
STANDARD CLOSURES
 
 
 
 
 
10.5
OTHERS
 
 
 
 
11
PHARMACEUTICAL CAPS AND CLOSURE PACKAGING MARKET, BY SEALING TECHNOLOGY (MARKET SIZE & FORECAST TO 2030 – IN VALUE, USD MILLION)
 
 
 
 
 
 
DEMAND POTENTIAL AND GROWTH PATHWAYS SHAPING PHARMACEUTICAL CAPS AND CLOSURE PACKAGING ADOPTION IN DIVERSE TECHNOLOGIES
 
 
 
 
 
 
11.1
INTRODUCTION
 
 
 
 
 
11.2
PHARMACEUTICAL MANUFACTURING
 
 
 
 
 
11.3
CONTRACT MANUFACTURING ORGANIZATIONS
 
 
 
 
 
11.4
BIOTECHNOLOGY COMPANIES
 
 
 
 
 
11.5
HEALTHCARE FACILITIES
 
 
 
 
 
11.6
RETAIL PHARMACIES
 
 
 
 
 
11.7
HOSPITALS & CLINICS
 
 
 
 
 
11.8
NUTRACEUTICALS
 
 
 
 
 
11.9
OTHERS
 
 
 
 
12
PHARMACEUTICAL CAPS AND CLOSURE PACKAGING MARKET, BY REGION (MARKET SIZE & FORECAST TO 2030 – IN VALUE, USD MILLION)
 
 
 
 
 
 
ASSESSING GROWTH PATTERNS, INDUSTRY FORCES, REGULATORY LANDSCAPE, AND MARKET POTENTIAL ACROSS KEY GEOGRAPHIES AND COUNTRIES
 
 
 
 
 
 
12.1
INTRODUCTION
 
 
 
 
 
12.2
ASIA PACIFIC
 
 
 
 
 
 
12.2.1
CHINA
 
 
 
 
 
12.2.2
JAPAN
 
 
 
 
 
12.2.3
INDIA
 
 
 
 
 
12.2.4
SOUTH KOREA
 
 
 
 
 
12.2.5
REST OF ASIA PACIFIC
 
 
 
 
12.3
NORTH AMERICA
 
 
 
 
 
 
12.3.1
US
 
 
 
 
 
12.3.2
CANADA
 
 
 
 
 
12.3.3
MEXICO
 
 
 
 
12.4
EUROPE
 
 
 
 
 
 
12.4.1
GERMANY
 
 
 
 
 
12.4.2
FRANCE
 
 
 
 
 
12.4.3
UK
 
 
 
 
 
12.4.4
ITALY
 
 
 
 
 
12.4.5
SPAIN
 
 
 
 
 
12.4.6
REST OF EUROPE
 
 
 
 
12.5
SOUTH AMERICA
 
 
 
 
 
 
12.5.1
BRAZIL
 
 
 
 
 
12.5.2
ARGENTINA
 
 
 
 
 
12.5.3
REST OF SOUTH AMERICA
 
 
 
 
12.6
MIDDLE EAST & AFRICA
 
 
 
 
 
 
12.6.1
GCC COUNTRIES
 
 
 
 
 
 
12.6.1.1
SAUDI ARABIA
 
 
 
 
 
12.6.1.2
REST OF GCC COUNTRIES
 
 
 
 
12.6.2
SOUTH AFRICA
 
 
 
 
 
12.6.3
REST OF MIDDLE EAST & AFRICA
 
 
 
13
COMPETITIVE LANDSCAPE
 
 
 
 
 
 
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
 
 
 
 
 
 
 
13.1
OVERVIEW
 
 
 
 
 
13.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN (2021–2025)
 
 
 
 
 
13.3
REVENUE ANALYSIS (2022–2024)
 
 
 
 
 
 
13.4
MARKET SHARE ANALYSIS (2024)
 
 
 
 
 
 
13.5
PRODUCT COMPARISON
 
 
 
 
 
 
13.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
 
 
 
 
 
 
 
13.6.1
STARS
 
 
 
 
 
13.6.2
EMERGING LEADERS
 
 
 
 
 
13.6.3
PERVASIVE PLAYERS
 
 
 
 
 
13.6.4
PARTICIPANTS
 
 
 
 
 
13.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
 
 
 
 
 
 
13.6.5.1
COMPANY FOOTPRINT
 
 
 
 
 
13.6.5.2
TYPE FOOTPRINT
 
 
 
 
 
13.6.5.3
MATERIAL FOOTPRINT
 
 
 
 
 
13.6.5.4
APPLICATION FOOTPRINT
 
 
 
 
 
13.6.5.5
SEALING TECHNOLOGY FOOTPRINT
 
 
 
 
 
13.6.5.6
REGION FOOTPRINT
 
 
 
13.7
COMPANY EVALUATION MATRIX: STARTUPS/SMES,
 
 
 
 
 
 
 
13.7.1
PROGRESSIVE COMPANIES
 
 
 
 
 
13.7.2
RESPONSIVE COMPANIES
 
 
 
 
 
13.7.3
DYNAMIC COMPANIES
 
 
 
 
 
13.7.4
STARTING BLOCKS
 
 
 
 
 
13.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
 
 
 
 
 
 
13.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
13.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
13.8
COMPANY VALUATION AND FINANCIAL METRICS
 
 
 
 
 
13.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
13.9.1
PRODUCT LAUNCHES
 
 
 
 
 
13.9.2
DEALS
 
 
 
 
 
13.9.3
EXPANSIONS
 
 
 
14
COMPANY PROFILES
 
 
 
 
 
 
IN-DEPTH REVIEW OF COMPANIES, PRODUCTS, SERVICES, RECENT INITIATIVES, AND POSITIONING STRATEGIES IN PHARMACEUTICAL CAPS AND CLOSURE PACKAGING MARKET LANDSCAPE
 
 
 
 
 
 
14.1
KEY PLAYERS
 
 
 
 
 
 
14.1.1
AMCOR
 
 
 
 
 
 
14.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
14.1.1.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
14.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
14.1.1.4
MNM VIEW
 
 
 
 
 
 
14.1.1.4.1
KEY STRENGTHS/RIGHT TO WIN
 
 
 
 
 
14.1.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
14.1.1.4.3
WEAKNESSES/COMPETITIVE THREATS
 
 
 
14.1.2
APTARGROUP
 
 
 
 
 
 
14.1.2.1
BUSINESS OVERVIEW
 
 
 
 
 
14.1.2.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
14.1.2.3
RECENT DEVELOPMENTS
 
 
 
 
 
14.1.2.4
MNM VIEW
 
 
 
 
14.1.3
GERRESHEIMER
 
 
 
 
 
 
14.1.3.1
BUSINESS OVERVIEW
 
 
 
 
 
14.1.3.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
14.1.3.3
RECENT DEVELOPMENTS
 
 
 
 
 
14.1.3.4
MNM VIEW
 
 
 
 
14.1.4
WEST PHARMACEUTICAL SERVICES
 
 
 
 
 
 
14.1.4.1
BUSINESS OVERVIEW
 
 
 
 
 
14.1.4.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
14.1.4.3
RECENT DEVELOPMENTS
 
 
 
 
 
14.1.4.4
MNM VIEW
 
 
 
 
14.1.5
SILGAN HOLDINGS
 
 
 
 
 
 
14.1.5.1
BUSINESS OVERVIEW
 
 
 
 
 
14.1.5.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
14.1.5.3
RECENT DEVELOPMENTS
 
 
 
 
 
14.1.5.4
MNM VIEW
 
 
 
 
14.1.6
WEENER PLASTICS GROUP
 
 
 
 
 
 
14.1.6.1
BUSINESS OVERVIEW
 
 
 
 
 
14.1.6.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
14.1.7.3
RECENT DEVELOPMENTS
 
 
 
 
 
14.1.6.4
MNM VIEW
 
 
 
 
14.1.7
BERICAP
 
 
 
 
 
 
14.1.7.1
BUSINESS OVERVIEW
 
 
 
 
 
14.1.7.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
14.1.7.3
RECENT DEVELOPMENTS
 
 
 
 
 
14.1.7.4
MNM VIEW
 
 
 
 
14.1.8
CLOSURE SYSTEMS INTERNATIONAL
 
 
 
 
 
 
14.1.8.1
BUSINESS OVERVIEW
 
 
 
 
 
14.1.8.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
14.1.8.3
RECENT DEVELOPMENTS
 
 
 
 
 
14.1.8.4
MNM VIEW
 
 
 
 
14.1.9
BORMIOLI PHARMA
 
 
 
 
 
 
14.1.9.1
BUSINESS OVERVIEW
 
 
 
 
 
14.1.9.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
14.1.9.3
RECENT DEVELOPMENTS
 
 
 
 
 
14.1.9.4
MNM VIEW
 
 
 
 
14.1.10
GUALA CLOSURES
 
 
 
 
 
 
14.1.10.1
BUSINESS OVERVIEW
 
 
 
 
 
14.1.10.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
14.1.10.3
RECENT DEVELOPMENTS
 
 
 
 
 
14.1.10.4
MNM VIEW
 
 
 
14.2
OTHER PLAYERS
 
 
 
 
15
RESEARCH METHODOLOGY
 
 
 
 
 
 
15.1
RESEARCH DATA
 
 
 
 
 
 
15.1.1
SECONDARY DATA
 
 
 
 
 
 
15.1.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
 
 
15.1.1.2
LIST OF KEY SECONDARY SOURCES
 
 
 
 
15.1.2
PRIMARY DATA
 
 
 
 
 
 
15.1.2.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
15.1.2.2
KEY PRIMARY PARTICIPANTS
 
 
 
 
 
15.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
 
 
 
 
 
15.1.2.4
KEY INDUSTRY INSIGHTS
 
 
 
15.2
MARKET SIZE ESTIMATION
 
 
 
 
 
 
15.2.1
BOTTOM-UP APPROACH
 
 
 
 
 
15.2.2
TOP-DOWN APPROACH
 
 
 
 
 
15.2.3
MARKET SIZE CALCULATION FOR BASE YEAR
 
 
 
 
15.3
MARKET FORECAST APPROACH
 
 
 
 
 
 
15.3.1
SUPPLY SIDE
 
 
 
 
 
15.3.2
DEMAND SIDE
 
 
 
 
15.4
DATA TRIANGULATION
 
 
 
 
 
15.5
FACTOR ANALYSIS
 
 
 
 
 
15.6
RESEARCH ASSUMPTIONS AND LIMITATIONS
 
 
 
 
 
15.7
RISK ASSESSMENT
 
 
 
 
16
APPENDIX
 
 
 
 
 
 
16.1
DISCUSSION GUIDE
 
 
 
 
 
16.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
16.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
16.4
RELATED REPORTS
 
 
 
 
 
16.5
AUTHOR DETAILS
 
 
 
 

Methodology

The study involved four major activities to estimate the current size of the Pharmaceutical Caps and Closure Packaging Market. Exhaustive secondary research was carried out to collect information on the market, the peer product market, and the parent product group market. The next step was to validate these findings, assumptions, and sizes with the industry experts across the value chain of pharmaceutical packaging through primary research. The top-down and bottom-up approaches were employed to estimate the overall size of the Pharmaceutical Caps and Closure Packaging Market. After that, market breakdown and data triangulation procedures were used to determine the size of different segments and sub-segments of the market.

Secondary Research

The market for the companies offering pharmaceutical packaging is arrived at by secondary data available through paid and unpaid sources, analyzing the product portfolios of the major companies in the ecosystem, and rating the companies by their performance and quality. Various secondary sources, such as Business Standard, Bloomberg, World Bank, and Factiva, were referred to in order to identify and collect information for this study on the Pharmaceutical Caps and Closure Packaging Market. In the secondary research process, various secondary sources were referred to identify and collect information related to the study. Secondary sources included annual reports, press releases, and investor presentations, forums, certified publications, and whitepapers. The secondary research was used to obtain critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from the market and technology-oriented perspectives.

Primary Research

In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from several key companies and organizations operating in the Pharmaceutical Caps and Closure Packaging Market. After the complete market engineering (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also conducted to identify the segmentation types, industry trends, competitive landscape of pharmaceutical packaging offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies. In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down and bottom-up approaches were used to estimate and validate the size of the Pharmaceutical Caps and Closure Packaging Market. These approaches were also used extensively to estimate the size of various dependent market segments. The research methodology used to estimate the market size included the following:

Pharmaceutical Caps and Closure Packaging Market : Top-Down and Bottom-Up Approach

Pharmaceutical Caps and Closure Packaging Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. The data triangulation procedure was employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Pharmaceutical packaging pertains to the materials and systems designed to protect, preserve, and deliver pharmaceutical products for oral, injectable, inhalation, and topical drug delivery modalities. It plays an important role in the stability and sterility of a drug, avoids contamination, and provides accurate dosing for the life of the product. Pharmaceutical packaging denotes the numerous varieties of available options, like plastic bottles, blister packs, vials, ampoules, prefillable syringes, tubes, pouches, and cartons to meet drug formulation requirements and regulatory obligations. Some of the significant functionalities of pharmaceutical packaging include moisture, oxygen, and light barrier protection, tamper evidence, patient convenience, and functionality with active pharmaceutical ingredients (APIs).

Areas of interest include ISO 15378 relating specifically to primary packaging materials, ISO 9001 regarding quality management systems, and GMP compliance. The DSCSA and the EU FMD identified serialized, tracking, and anti-counterfeiting programs, creating an opportunity for the packaging industry to help with drug quality and patient safety.

Stakeholders

  • Pharmaceutical packaging manufacturers
  • Raw material suppliers
  • Converters & processors
  • Distributors and traders
  • Industry associations and regulatory bodies
  • End users

Report Objectives

  • To define, describe, and forecast the size of the Pharmaceutical Caps and Closure Packaging Market, based  on type, packaging type, drug delivery, raw material, and region in terms of value and volume
  • To provide detailed information on the significant drivers, restraints, opportunities, and challenges influencing the market
  • To strategically analyze micromarkets concerning individual growth trends, prospects, and their contribution to the market
  • To assess the growth opportunities in the market for stakeholders and provide details on the competitive landscape for market leaders
  • To forecast the market size of segments and subsegments for North America, Europe, Asia Pacific, South America, and the Middle East & Africa
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • To analyze competitive developments such as acquisitions, product launches, expansions, partnerships, and agreements in the Pharmaceutical Caps and Closure Packaging Market
  • To provide the impact of AI/Gen AI on the market

Available Customizations

With the given market data, MarketsandMarkets offers customizations according to client-specific needs.

The following customization options are available for the Pharmaceutical Caps and Closure Packaging Market report:

Product Analysis

  • A product matrix that gives a detailed comparison of the product portfolio of each company

Geographic Analysis as per Feasibility

  • A further breakdown of the Pharmaceutical Caps and Closure Packaging Market for additional countries

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

 

Growth Signals

See competitors, opportunities & growth signals

Explore Intelligence

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Pharmaceutical Caps and Closure Packaging Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Pharmaceutical Caps and Closure Packaging Market

What the Report Didn't Show You? Turn research into consulting-grade strategic intelligence.
15+ outputs | Interactive dashboards | Proprietary data
Explore with GrowthIQ →
DMCA.com Protection Status